Program Schedule

68
Antimicrobial Stewardship—The Latest Trends and Opportunities

Thursday, October 9, 2014: 3:45 PM-5:45 PM
Room: The Pennsylvania Convention Center: 103-ABC
Co-organized with the Society of Infectious Diseases Pharmacists

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify the processes and approaches to antimicrobial de-escalation and shortening duration of therapy for bacterial infection
  • describe the role of antimicrobial stewardship as a component of bundled approaches for the prevention of healthcare-associated infection and antimicrobaial resistance
  • discuss the growing role of antimicrobial stewardship in long-term care

Target Audience: Researchers, Pharmacists, Nurses, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Hospital administrators, Health care workers, Fellows, Epidemiologists, Clinicians

Tracks: Pediatric ID, Epidemiology and Infection Control, Adult ID

Moderators:  Keith Kaye, MD, MPH, FIDSA, FSHEA, Detroit Medical Center/ Wayne State University and Elizabeth Dodds Ashley, PharmD, MHS, University of Rochester Medical Center

Presentations:
3:45 PM
545
De-Escalation and Duration of Therapy - How Low Can We Go?
Thomas M. File Jr., MD, MSc, MACP, FIDSA, FCCP
4:45 PM
547

CME Credits: Maximum of 2 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 2.0 knowledge-based contact hours (0.2 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-110-L01-P

Disclosures:

K. Kaye, Theradoc: Speaker's Bureau, Speaker honorarium

E. Dodds Ashley, None

T. M. File Jr., None

E. Dodds-Ashley, Cubist Pharmaceuticals: Scientific Advisor, travel reimbursement

C. Crnich, None

S. Harbarth, BioMerieux: Consultant, Consulting fee

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek